orlistat and Cholestasis

orlistat has been researched along with Cholestasis* in 1 studies

Other Studies

1 other study(ies) available for orlistat and Cholestasis

ArticleYear
[A case of acute cholestatic hepatitis associated with Orlistat].
    Taehan Kan Hakhoe chi = The Korean journal of hepatology, 2002, Volume: 8, Issue:3

    Orlistat(Xenical(R), Roche) is considered a safe and effective drug to treat obesity by reduced absorption of 30% digested fat. To date, no serious adverse effects affecting the liver have been published except a case of subacute hepatic failure leading to liver transplantation in a young women with moderate obesity treated with orlistat. We report a case of acute cholestatic hepatitis in a young woman with moderate obesity treated with orlistat: a 33-year-old female admitted for the evaluation of jaundice. Abdominal ultrasonography, ERCP, routine chemistry, viral markers, and a fine needle biopsy of liver were performed. Microscopic findings of the liver biopsy specimen were compatible with acute cholestatic hepatitis. After steroid therapy, liver function was improved.

    Topics: Acute Disease; Adult; Anti-Obesity Agents; Chemical and Drug Induced Liver Injury; Cholestasis; Female; Humans; Lactones; Lipase; Orlistat

2002